Plasma and Muscle Myostatin in Relation to Type 2 Diabetes
Open Access
- 16 May 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (5) , e37236
Abstract
Myostatin is a secreted growth factor expressed in skeletal muscle tissue, which negatively regulates skeletal muscle mass. Recent animal studies suggest a role for myostatin in insulin resistance. We evaluated the possible metabolic role of myostatin in patients with type 2 diabetes and healthy controls. 76 patients with type 2 diabetes and 92 control subjects were included in the study. They were matched for age, gender and BMI. Plasma samples and biopsies from the vastus lateralis muscle were obtained to assess plasma myostatin and expression of myostatin in skeletal muscle. Patients with type 2 diabetes had higher fasting glucose (8.9 versus 5.1 mmol/L, P<0.001), plasma insulin (68.2 versus 47.2 pmol/L, P<0.002) and HOMA2-IR (1.6 versus 0.9, P<0.0001) when compared to controls. Patients with type 2 diabetes had 1.4 (P<0.01) higher levels of muscle myostatin mRNA content than the control subjects. Plasma myostatin concentrations did not differ between patients with type 2 diabetes and controls. In healthy controls, muscle myostatin mRNA correlated with HOMA2-IR (r = 0.30, P<0.01), plasma IL-6 (r = 0.34, P<0.05) and VO2 max (r = −0.26, P<0.05), however, no correlations were observed in patients with type 2 diabetes. This study supports the idea that myostatin may have a negative effect on metabolism. However, the metabolic effect of myostatin appears to be overruled by other factors in patients with type 2 diabetes.Keywords
This publication has 31 references indexed in Scilit:
- Postnatal PPARδ Activation and Myostatin Inhibition Exert Distinct yet Complimentary Effects on the Metabolic Profile of Obese Insulin-Resistant MicePLOS ONE, 2010
- Leptin Administration Favors Muscle Mass Accretion by Decreasing FoxO3a and Increasing PGC-1α in ob/ob MicePLOS ONE, 2009
- Gene Expression in Skeletal Muscle Biopsies from People with Type 2 Diabetes and Relatives: Differential Regulation of Insulin Signaling PathwaysPLOS ONE, 2009
- Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administrationMolecular and Cellular Endocrinology, 2009
- Myostatin Inhibition in Muscle, but Not Adipose Tissue, Decreases Fat Mass and Improves Insulin SensitivityPLOS ONE, 2009
- Loss-of-Function Mutation in Myostatin Reduces Tumor Necrosis Factor α Production and Protects Liver Against Obesity-Induced Insulin ResistanceDiabetes, 2009
- Increased Secretion and Expression of Myostatin in Skeletal Muscle From Extremely Obese WomenDiabetes, 2009
- Clinical, Agricultural, and Evolutionary Biology of Myostatin: A Comparative ReviewEndocrine Reviews, 2008
- Muscle wasting in diabetic and in tumor-bearing rats: Role of oxidative stressFree Radical Biology and Medicine, 2008
- Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effectsProceedings of the National Academy of Sciences, 2006